Rezolute FY26 net loss widens 4.26% to $77.59 million; FY26 G&A expenses climb 58.79% to $29.17 million
Bitget2026/09/24 20:06- Rezolute posted a fiscal 2026 net loss of USD 77.59 million, widening from USD 74.41 million a year earlier.
- R&D expense fell 12.56% to USD 53.8 million, and the company attributed the drop mainly to lower ersodetug manufacturing costs.
- G&A expense climbed 58.8% to USD 29.17 million, which it linked to higher stock-based compensation and pre-commercial professional fees.
- Cash, cash equivalents and marketable securities totaled USD 107.8 million at June 30, 2026, down from USD 167.9 million.
- Phase 3 upLIFT tumor HI study enrollment continues, with topline results expected before end-2026; sunRIZE congenital HI data remain under FDA review.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Half a million miners stand between Bolivia and a critical minerals rush
US factory orders rose by 0.1% month-on-month in August; AI infrastructure supports manufacturing, but decline in aircraft orders offset part of the increase
The U.S. Census Bureau reported on Friday that factory orders in August increased by 0.1% month-on-month, in line with market expectations, and rose by 6.8% year-on-year. The July month-on-month increase was revised down from 0.9% to 0.8%. Orders for machinery and electrical equipment grew by 1.1% month-on-month, while orders for civilian aircraft and parts saw a significant decline of 4.3% month-on-month. Excluding aircraft, non-defense capital goods orders increased by 1.6% month-on-month.
ONDO falls below $0.5
Crypto prices
More
